Oxypurinol alkali and alkalane earth salts in amorphous or cryst

Details Oxypurinol alkali and alkalane earth salts in amorphous or cryst Oxypurinol alkali and alkalane earth salts in amorphous or cryst

1993-01-19

1995-07-04

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3152

Patent

active

054300371

ABSTRACT:
Treatment of hyperuricaemia and gout is possible by agents, among usual carriers and adjuvants containing pharmakologically active doses of oxypurinol alkali and/or alkaline earth salts in amorphous or crystalline form.

REFERENCES:
Handbook of Pharmaceutical Excipients (1986) pp. 138-140.
Martindale, The Extra Pharmacopeia, 28th edition (1982) pp. 417-419.

Affiliated with

Also associated with

Rating

Oxypurinol alkali and alkalane earth salts in amorphous or cryst does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxypurinol alkali and alkalane earth salts in amorphous or cryst, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxypurinol alkali and alkalane earth salts in amorphous or cryst will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-760307